Disease-Modifying Potential of BET Inhibitor Pelabresib (CPI-0610) As Demonstrated By Improvements in Bone Marrow Function and Clinical Activity in Patients with Myelofibrosis - Preliminary DataSrđan Verstovšek, Claire Harrison, John Mascarenhas et al.|Blood|2021Cited by 9